Trilogy Announces the 2022 QualiT™ Tour

Press Release: 6/16/2022

For Immediate Release

Trilogy Analytical Laboratory is excited to announce the new 2022 QualiT™ Tour.

 “Our goal with the new QualiT™ Tour is to help organizations harmonize their quality system before the busy harvest season. Early signs point to a mix of different mycotoxins for the 2022 harvest. The QualiT Tour will provide companies and organizations with quality information, tips and counseling before the busy harvest season begins. The best part of the program is that it’s available at no cost! No strings attached whatsoever,” says Jordon Bierbaum, Trilogy Vice-President of Operations.

In an effort to help organizations either build, maintain or improve on their current quality plan, Trilogy has developed a consultative program to help companies achieve their quality goals. “One of the biggest challenges, but also the most rewarding, is helping others identify problem areas of a quality plan before issues arise. We’re offering to help companies identify those potential problem areas of their mycotoxin testing plan and assist them in developing a realistic solution,” says Jenny Rodgers, Trilogy Quality Manager.

About Trilogy

Trilogy is a food and feed safety laboratory specializing in mycotoxins, mycotoxin binder analysis, biogenic amines and animal drug residue testing. Trilogy Analytical Laboratory opened its doors in 1999 when its founders recognized a need in the mycotoxin industry for quick result turn-around utilizing reliable reference methods provided in an analytical setting. One of the main pillars of Trilogy’s strategy is to operate using a comprehensive quality program that we can rely on to ensure performance parameters are met every single time. From this philosophy the Trilogy line of quality products was born with the mycotoxin industry in mind.

Media Contact: Lynette Hischier,